RT Journal Article
SR Electronic
T1 Frequency Of pRenatal CAre viSiTs (FORCAST): study protocol to develop a core outcome set for prenatal care schedules
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.17.23288705
DO 10.1101/2023.04.17.23288705
A1 Turrentine, Mark
A1 Nguyen, Buu-Hac
A1 Choby, Beth
A1 Kendig, Susan
A1 King, Tekoa L.
A1 Kotelchuck, Milton
A1 Simas, Tiffany A. Moore
A1 Srinivas, Sindhu K.
A1 Zahn, Christopher M.
A1 Peahl, Alex Friedman
YR 2023
UL http://medrxiv.org/content/early/2023/04/19/2023.04.17.23288705.abstract
AB Background Prenatal care, one of the most common preventive care services in the United States, endeavors to improve pregnancy outcomes through evidence-based screenings and interventions. Despite the prevalence of prenatal care and its importance to maternal and infant health, there are several debates about the best methods of prenatal care delivery, including the most appropriate schedule frequency and content of prenatal visits. Current U.S. national guidelines recommend that low-risk individuals receive a standard schedule of 12 to 14 in-office visits, a care delivery model that has remained unchanged for almost a century.Objectives In early 2020, to mitigate individuals’ exposure to the SARS-CoV-2 virus, prenatal care providers implemented new paradigms that altered the schedule frequency, interval, and modality (e.g., telemedicine) of how prenatal care services were offered. In this manuscript, we describe development of a core outcome set (COS) that can be used to evaluate the effect of the frequency of prenatal care schedules on maternal and infant outcomes.Methods We will systematically review the literature to identify previously reported outcomes important to individuals who receive prenatal care and the people who care for them. Stakeholders with expertise in prenatal care delivery (i.e., patients/family members, healthcare providers, and public health professionals and policymakers) will rate the importance of identified outcomes in an online survey using a three-round Delphi process. A virtual consensus meeting will be held for a group of stakeholder representatives to discuss and vote on the outcomes to include in the final COS.Results The Delphi survey was initiated in July 2022 with 71 stakeholders invited. A virtual consensus conference was conducted on October 11, 2022. Data is currently under analysis.Conclusions More research about the optimal schedule frequency and modality for prenatal care delivery is needed. Standardizing outcomes that are measured and reported in evaluations of the recommended prenatal care schedules will assist evidence synthesis and results reported in systematic reviews and meta-analyses. Overall, this COS will expand the consistency and patient-centeredness of reported outcomes for various prenatal care delivery schedules and modalities, hopefully improving the overall efficacy of recommended care delivery for pregnant people and their families.Trial Registration This study was registered in the Core Outcome Measures for Effectiveness (COMET) database on January 18, 2022, registration #2021 http://www.comet-initiative.org/Studies/Details/2021.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols http://www.comet-initiative.org/Studies/Details/2021. http://www.comet-initiative.org/Studies/Details/2021. Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was determined exempt by the University of Michigan institutional review board, as it was deemed non-human subject research (HUM00217486).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll datasets used and/or analyzed during the FORCAST study will be held by the FORCAST team at alexfrie@med.umich.edu.FORCASTFrequency Of pRenatal CAre viSiTsCOScore outcome setCOMETCore Outcome Measures for EffectivenessACOGAmerican College of Obstetricians and Gynecologists